06/25/16 – Press release: FDA grants QIDP and Fast Track Designations to MCB3837

pdf-dateiformat-symbol_318-45340-e1467297671859


06/22/16 – Press release: Morphochem’s Investigational New Drug (IND) application accepted by the FDA

pdf-dateiformat-symbol_318-45340-e1467297671859

04/10/16 – Morphochem presentation at ECCMID Pipeline Corner:
http://www.eccmid.org/scientific_programme/pipeline_corner/
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) offers to small, innovative pharmaceutical companies with early-stage antimicrobial therapies in development a platform to present their products to a wider audience.

pdf-dateiformat-symbol_318-45340-e1467297671859

Back